Despite recent gains, the TSX is still 9% below its value on January 1, 2020, thanks to COVID-19.
However, a quick analysis, using Stock Target Advisor’s stock screening tool shows that 83 out of the 355 large-cap (i.e market cap > $ 1B) company stocks on the TSX are showing positive YTD gains.
The top performers among these 83Â COVID-19 immune stocks are the following 5 companies:
- Shopify (104 % YTD Gain)
- Real Matters (92 % YTD Gain)
- Andlauer Healthcare (82 % YTD Gain)
- Kinaxis (67 % YTD Gain)
- Ballard Power Systems (60 % YTD Gain)
All are ahead of recent analyst targets and overpriced compared to other companies in their sectors and hence it may be too late to add them to your portfolio. However, it is worth looking at the ETFs which contain these stocks, or their underpriced peers to identify other opportunities.
You can scroll down the detailed analysis pages on Stock Target Advisor for each of these stocks to look at their peers and ETFs which contain them and look at what the analysts and Stock Target Advisor’s analysis are saying to see if there are still assets available with upside potential.
Happy hunting !
